Health Care/Hospital

Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis

SAN DIEGO, SHANGHAI and SYDNEY, Aug. 15, 2023 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a clinical stage biotechnology company developing innovative and differentiated therapies for immunological and inflammatory diseases, announced that the first patient has been dosed in a glob...

2023-08-15 22:50 2358

Former U.S. Representative Patrick J. Kennedy Joins Holmusk as a Strategic Advisor

Kennedy to champion development of measurement standards to improve behavioral health care NEW YORK, Aug. 15, 2023 /PRNewswire/ -- Holmusk , a leading global behavioral health real-world evidence company, today announced that former U.S. Representative and longtime ment...

2023-08-15 20:00 1447

OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors

NEW YORK, Aug. 15, 2023 /PRNewswire/ -- OnCusp Therapeutics, a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide, announced today the clearance of its Investigational New Drug (IND) Applicatio...

2023-08-15 20:00 1165

Hong Kong Department of Health has Approved the Registration Applications for the Uro-G and Uro-V Disposable Cystoscopic System

SHANGHAI, Aug. 15, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Government of Hong Kong Specia...

2023-08-15 16:52 1939

Orthopedic brace can help reduce pain from Hallux Valgus - The Footing Health K releases Toe braces!

* Launch of an instrument to correct bunions SEOUL, South Korea, Aug. 14, 2023 /PRNewswire/ -- When the toes are corrected, our entire body shape, starting from the toes, is corrected. The process of correction starting from the toe can be seen as a process of correcting the connection between ...

2023-08-14 20:00 1265

Neurophth Secures Nearly 95 Million USD in Series C+ Financing for Gene Therapy Clinical Trials

WUHAN, China and SAN DIEGO, Aug. 11, 2023 /PRNewswire/ -- Neurophth Therapeutics, Inc. ("Neurophth"), aChina's leading gene therapy company for ophthalmic diseases, announced the closing of nearly95 million USD in Series C+ financing. The round was co-led by Yangtze River-CMB International Indust...

2023-08-11 21:00 2618

Nano Labs to Announce First Half of 2023 Financial Results on August 15, 2023

HANGZHOU, China, Aug. 11, 2023 /PRNewswire/ -- Nano Labs Ltd (Nasdaq: NA) ("we," the "Company" or "Nano Labs"), a leading fabless integrated circuit design company and product solution provider inChina, today announced that it will report its unaudited financial results for the first half of 2023...

2023-08-11 20:00 4910

Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer

SHANGHAI, Aug. 11, 2023 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that the Phase III bridging clinical tr...

2023-08-11 17:00 3938

WuXi XDC and Boostimmune Sign MOU for Integrated Services

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating ...

2023-08-11 08:30 1594

WuXi Biologics and Boostimmune Sign MOU for Exclusive Research and Discovery Services

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating the tumor immune micr...

2023-08-11 08:30 4360

Datasea Launches Innovative "Intelligent Acoustics" Subsidiary in Delaware, Unveiling AI-Integrated Offerings for US Market

BEIJING, Aug. 10, 2023 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology corporation engaged in three converging and innovative business segments inChina: intelligent acoustics, 5G messaging, and smart city technology, announced the inception of a who...

2023-08-10 21:30 3579

HitGen Enters into DNA-Encoded Library Based Research Service Agreement with Nested Therapeutics

CHENGDU, China, Aug. 10, 2023 /PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research service agreement with Nested Therapeutics, Inc. ("Nested"), a biotechnology company pioneering a next-generation precisi...

2023-08-10 21:30 1945

Standigm and Nashville Biosciences join to revolutionize early drug discovery

Companies will identify novel therapeutic targets using Standigm's explainable AI and Nashville Biosciences' datasets SEOUL, South Korea, Aug. 10, 2023 /PRNewswire/ -- Standigm , a company using artificial intelligence (AI) technology for drug discovery and develop...

2023-08-10 21:07 1495

Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact

SHANGHAI, Aug. 10, 2023 /PRNewswire/ -- August 10, 2023, in a groundbreaking development, Oricell Therapeutics Co., Ltd. ("Oricell") has received the green light for its Investigational New Drug (IND) application of OriCAR-017, a cutting-edge CAR-T cell therapy targeting GPRC5D to combat relapsed...

2023-08-10 21:00 2261

Clarity's theranostic prostate cancer trial advances to highest dose level

Highlights * Cohort 2 of the theranostic SECuRE trial investigating 64Cu/67Cu SAR-bisPSMA in metastatic castrate-resistant prostate cancer (mCRPC) has been completed in 3 participants who received therapy with67Cu SAR-bisPSMA at the dose level of 8GBq. * No dose limiting toxicities (DLTs) ha...

2023-08-10 20:58 2370

Baird Medical Submits Disposable Microwave Ablation Needle and MWA System Application to U.S. FDA for Treatment of Soft Tissue Microwave Ablation

GUANGZHOU, China, Aug. 10, 2023 /PRNewswire/ -- Baird Medical Investment Holdings Limited ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider inChina, today announced the 510(k) premarket notification submission of the Company's Disposabl...

2023-08-10 19:00 1871

Mediballoon's Online Shop is now live, offering a range of medical balloons and tubing for sale. Mediballoon is your best partner for medical device development.

UNION CITY, Calif., Aug. 9, 2023 /PRNewswire/ -- Mediballoon, Inc., a Medeologix company established in 2016 specializing in medical balloon design, development, and scale-up production, is excited to announce the launch of the Mediballoon Online Shop. This newly unveiled platform caters to engin...

2023-08-09 23:00 1467

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

HAIKOU, China, Aug. 9, 2023 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its wholly-owned subsidiary Hainan Helpson Medical & Biotechnology Co., Ltd. (hereinafter referred to as ...

2023-08-09 20:30 1981

Zepp Health Corporation to Report Second Quarter 2023 Financial Results on August 21, 2023

Earnings Call Scheduled for 8:30 a.m. ET on August 21, 2023 BEIJING, Aug. 9, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it will report it...

2023-08-09 20:00 4350

Mindray and Operation Smile Begin 10-Year Partnership to Improve Healthcare for Vulnerable Communities

SHENZHEN, China, Aug. 8, 2023 /PRNewswire/ -- Mindray, a leading global provider of medical devices and solutionsand Operation Smile, a global nonprofit dedicated to transforming the lives of patients and their communities by increasing access to safe surgery and providing high-quality cleft surg...

2023-08-09 11:17 1590
1 ... 80818283848586 ... 277

Week's Top Stories